[1] 李新章,文丹,何卫东.眼镜蛇毒临床应用研究概述[J]. 蛇志,2020,32(1):29-31. [2] LI A,ZHANG C,WANG J,et al.Cloning,expression,purification and bioactivity evaluation of a thrombin-like enzyme from Deinagkistrodon acutus venom gland library[J]. Biotechnology letters,2018,40(1):93-102. [3] WANG S S,XU X L,GAO S, et al.Purification and partial characterization of a novel fibrinogenase from the venom of Deinagkistrodon acutus:Inhibition of platelet aggregation[J]. Protein expression and purification,2014,99:99-105. [4] ZHENG Y,YE F P,WANG J,et al.Purification,characterization and gene cloning of Da-36,a novel serine protease from Deinagkistrodon acutus venom[J]. Toxicon,2013,67:1-11. [5] TANG S S, WANG X H, ZHANG J H, et al.Biochemical properties and comparative pharmacology of a coagulant from Deinagkistrodon acutus snake venom[J]. European journal of pharmaceutical sciences,2013,49(1):90-98. [6] 向泽初,刘礼孝.三蛇药酒临床应用117例药效观察[J]. 蛇志,1995(1):53-56. [7] DOLEY R, KINI R M.Protein complexes in snake venom[J]. Cell Mol Life Sci,2009,66(17):2851-2871. [8] SANCHEZ E F, FLORES-ORTIZ R J, ALVARENGA V G, et al. Direct fibrinolytic snake venom metalloproteinases affecting hemostasis:Structural,biochemical features and therapeutic potential[J]. Toxins,2017,9(12):392. [9] 黄春洪, 孔毅, 吴杰连,等. 尖吻蝮蛇毒素组双向电泳和二维液相色谱研究[J]. 中国药科大学学报, 2006(2): 169-173. [10] J.萨姆布鲁克,D.W.拉塞尔.分子克隆实验指南(3版)[M]. 黄培堂,译.北京:科学出版社,2002. [11] 肖纲, 刘俊琦, 夏雨,等. 湖南永州尖吻蝮蛇蛇毒的蛋白组分及毒性分析[J]. 湖南农业大学学报(自然科学版), 2019, 45(5): 541-547. [12] 肖纲. 湖南两种蛇毒的成分分析及毒性研究[D]. 长沙:湖南农业大学,2021. [13] 叶文娟,冉永禄,赖仞,等. 尖吻蝮蛇蛇毒出血毒素的纯化与部分性质[J]. 蛇志,1999(3): 21-24. [14] 连琪. 华游蛇强效抗蛇毒能力的分子基础及其活性成分的作用机制研究[D]. 南昌:南昌大学,2023. [15] 丁锐,王奎龙,沈梦丹,等.醋制商陆正丁醇部位降低肝肾毒性作用机制研究[J]. 中草药,2023,54(3):798-807. [16] 贺玲,向泽初,孔天翰.尖吻蝮蛇毒酒的研制[J]. 蛇志,2010,22(1):52. [17] 郭鹏举,严若谷,李其斌,等.乙醇对中华眼镜蛇毒毒性的影响[J]. 蛇志,2011,23(4):348-350. [18] 李其斌,郭鹏举,王威,等.乙醇对五步蛇(Agkistrodon acutus)毒毒性的影响[J]. 蛇志,2011,23(3):232-234. |